Quality – Reliability – Innovation. With these three strong principles, BIOIATRIKI Healthcare Group in Cyprus achieved, for the fourth consecutive year, top distinctions at the Cyprus Healthcare Business Awards 2024. More specifically, the Group received a gold award in the category of "Quality of Services and Patient Care" and two silver awards in the categories of "Innovative Equipment" for its Polydynamo Medical and Diagnostic Center, and "Outstanding Business Performance, Investment Activity, and/or Contribution to Employment."
The goal of the event was to highlight and reward excellence among businesses and professionals in the healthcare sector.
The Director of Operations and Development of the BIOIATRIKI Healthcare Group in Cyprus, Mr. Anastasios Kalogiannis, upon receiving the three awards, expressed his gratitude to all those who trust the Group for their medical tests, while emphasizing the values that govern the Group's operations, which reflect its commitment to the “Quality-Reliability-Innovation” culture. "We are here to provide upgraded services to all citizens, without exception," he stated.
BIOIATRIKI Healthcare Group has been operating in Cyprus since 2017, taking on the establishment, staffing, and operation of the clinical laboratory at the German Oncology Center. The Group is also the major shareholder of Yiannoukas Medical Laboratories and the ALFA EVRESIS Diagnostic Center. In 2022, Pavlidis Medical Laboratories also joined the Group, thus upgrading and improving the clinical laboratory services for patients in the Limassol and Paphos districts. The Group – a pioneer in the field of Primary Healthcare – was the first to introduce the concept of a Polydynamo Diagnostic Center in Cyprus. It stands out for its innovative, state-of-the-art equipment, both in diagnostic tests and clinical laboratory examinations, as well as for its highly trained scientific staff.
